Source: http://tobaccocontrol.bmj.com
Authors: Adrienne B Mejia et al.

Background:
Snus (a form of smokeless tobacco) is less dangerous than cigarettes. Some health professionals argue that snus should be promoted as a component of a harm reduction strategy, while others oppose this approach. Major US tobacco companies (RJ Reynolds and Philip Morris) are marketing snus products as cigarette brand line extensions. The population effects of smokeless tobacco promotion will depend on the combined effects of changes in individual risk with population changes in tobacco use patterns.

Objective:
To quantitatively evaluate the health impact of smokeless tobacco promotion as part of a harm reduction strategy in the US.

Methods:
A Monte Carlo simulation of a decision tree model of tobacco initiation and use was used to estimate the health effects associated with five different patterns of increased smokeless tobacco use.

Results:
With cigarette smoking having a health effect of 100, the base case scenario (based on current US prevalence rates) yields a total health effect of 24.2 (5% to 95% interval 21.7 to 26.5) and the aggressive smokeless promotion (less cigarette use and increased smokeless, health-concerned smokers switching to snus, smokers in smokefree environments switching to snus) was associated with a health effect of 30.4 (5% to 95% interval 25.9 to 35.2). The anticipated health effects for additional scenarios with lower rates of smokeless uptake also overlapped with the base case.

Conclusions:
Promoting smokeless tobacco as a safer alternative to cigarettes is unlikely to result in substantial health benefits at a population level.

Authors: Adrienne B Mejia1, Pamela M Ling2, Stanton A Glantz3

Authors’ affiliations:
1Center for Tobacco Control Research and Education, University of California, San Francisco, USA
2Division of General Internal Medicine, Department of Medicine, Center for Tobacco Control Research and Education, University of California, San Francisco, USA
3Division of Cardiology and the Philip R Lee Institute for Health Policy Studies, Department of Medicine, Center for Tobacco Control Research and Education, University of California, San Francisco, USA